Strong growth for all Terumo's businesses
This article was originally published in Clinica
The Japanese company Terumo described the year as being one of "considerable progress", despite unstable exchange rates, further regulation of medical fees and increased competition. The company has ambitious plans to boost turnover to become a ¥00 billion ($1.5 billion) company within three years. In the year ended March 31 1997, the company's annual sales rose 14% to Yen138 billion ($1.1 billion), and net income rocketed 289% to Yen12.5 billion.